Taylor McLinden
Overview
Explore the profile of Taylor McLinden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Closson K, Nicholson V, Lee M, McLinden T, Cassidy-Matthews C, Card K, et al.
AIDS Care
. 2022 Sep;
35(2):296-305.
PMID: 36169492
Little is known about how the co-occurrence of psychosocial factors affect sub-populations of people living with HIV (PLWH). We used cross-sectional data from 999 PLWH, aged ≥19, accessing antiretroviral therapy...
12.
Haber N, Wieten S, Rohrer J, Arah O, Tennant P, Stuart E, et al.
Am J Epidemiol
. 2022 Aug;
191(12):2084-2097.
PMID: 35925053
We estimated the degree to which language used in the high-profile medical/public health/epidemiology literature implied causality using language linking exposures to outcomes and action recommendations; examined disconnects between language and...
13.
McClean A, Trigg J, Ye M, McLinden T, Kooij K, Bacani N, et al.
CMAJ Open
. 2022 Mar;
10(1):E183-E189.
PMID: 35292476
Background: Socioeconomic status has been associated with higher viral loads and lower CD4 cell counts among people living with HIV. The objective of this study was to evaluate the relation...
14.
Evolving patterns of antiretroviral drug interactions in people with HIV in British Columbia, Canada
Lepik K, Wang L, Harris M, McLinden T, Guliani S, Akagi L, et al.
AIDS
. 2022 Mar;
36(8):1105-1115.
PMID: 35285822
Objectives: To characterize the annual prevalence of antiretroviral/nonantiretroviral drug interactions in relation to antiretroviral therapy (ART)-prescribing patterns, and to describe drug interaction-related ART changes. Design/methods: This cohort study included ART-treated...
15.
Nanditha N, Dong X, McLinden T, Sereda P, Kopec J, Hogg R, et al.
BMC Med Res Methodol
. 2022 Jan;
22(1):1.
PMID: 34991473
Background: We described the impact of different lengths of lookback window (LW), a retrospective time period to observe diagnoses in administrative data, on the prevalence and incidence of eight chronic...
16.
Nanditha N, Zheng G, Tafessu H, McLinden T, Bratu A, Kopec J, et al.
Can J Public Health
. 2021 Aug;
112(6):1030-1041.
PMID: 34462891
Objectives: Longer survival has increased the likelihood of antiretroviral-treated people living with HIV (PLWH) developing age-associated comorbidities. We compared the burden of multimorbidity and all-cause mortality across HIV status in...
17.
McClean A, Kooij K, Trigg J, Ye M, Sereda P, McLinden T, et al.
AIDS Care
. 2021 Jun;
34(8):982-991.
PMID: 34074181
We assessed the relationship between tobacco smoking and immunologic and virologic response among people living with HIV (PLWH) initiating combination antiretroviral therapy (cART) in the Canadian HIV Observational Cohort (CANOC)....
18.
Bratu A, McLinden T, Kooij K, Ye M, Li J, Trigg J, et al.
BMJ Open
. 2021 May;
11(5):e048744.
PMID: 33980535
Introduction: People living with HIV (PLHIV) are increasingly at risk of age-related comorbidities such as diabetes mellitus (DM). While DM is associated with elevated mortality and morbidity, understanding of DM...
19.
Lima V, Wang L, Sereda P, McLinden T, Barrios R, Montaner J
PLoS One
. 2021 Feb;
16(2):e0246135.
PMID: 33577551
Introduction: Several methods have been proposed to estimate the time of HIV seroconversion, including those based on CD4 cell depletion models. However, previous models have failed to consider the heterogeneity...
20.
Nanditha N, Paiero A, Tafessu H, St-Jean M, McLinden T, Justice A, et al.
BMJ Open
. 2021 Jan;
11(1):e041734.
PMID: 33419911
Objectives: As people living with HIV (PLWH) live longer, morbidity and mortality from non-AIDS comorbidities have emerged as major concerns. Our objective was to compare prevalence trends and age at...